11 July 2019 Written by CN1699 Services Article viewed 7 times (6 times in the last week)

BraveHeart Wireless Inc., a leading innovator in clinical-quality biometric wearables, today announced that the company received clearance from the U.S. Food and Drug Administration (FDA) for the BraveHeart™ Life Sensor Cardiac Monitoring system.

The Life Sensor Cardiac Monitoring system is intended for use by health care professionals within a health care setting. The system captures heart rate and EKG data using a Life Sensor electrode affixed to a patient’s skin and continuously transmits the data from the electrode to an application on an iOS device, where the data can be reviewed by health care professionals.

For more information, visit:

BraveHeart | Cardiac


Read more related topics:

Cardiology 

Grace T

Managing Editor - CN1699 Services